Colleen Kraft

Last updated

Colleen Kraft
Born
Colleen Suzanne Kendrick [1]

(1976-10-30) October 30, 1976 (age 46)
Alma mater Taylor University, BA (1998)
Indiana University School of Medicine, MD (2002)
Emory University, MSc (2013)
Known forResponse to Ebola and COVID-19 outbreaks
Children3
Scientific career
Fields Infectious Diseases
Institutions Emory University
Website Research website

Colleen S. Kraft is an infectious disease physician, associate professor in the Department of Pathology and Laboratory Medicine, and the director of the Clinical Virology Research Laboratory at Emory University School of Medicine. In 2014, she led Emory University Hospital's effort to treat and care for Ebola virus disease patients and is currently working to address the COVID-19 pandemic in Georgia. She currently serves on Georgia's COVID-19 task force.

Contents

Education

Kraft received her Bachelor of Arts degree from Taylor University in Biology with a pre-medicine concentration in 1998. She then attended Indiana University School of Medicine, where she received her Doctor of Medicine degree in 2002. [2] She then performed her residency in Internal Medicine and fellowship in Infectious Disease and Medical Microbiology at Emory University. She later received her Master of Science in clinical research from Emory University in 2013. [2]

Career

Kraft became an assistant professor at Emory University School of Medicine in 2010 and was promoted to associate professor in 2016. She became the Associate Chief Medical Officer of Emory University Hospital in January 2020. [2] Her research interests include fecal microbiota transplants, building a large solid organ transplant population at Emory University Hospital to treat antibiotic resistant and hospital-acquired infections of Clostridioides difficile. [3] [4] [5] In addition, she has both studied and advanced clinical care of Ebola virus disease and COVID-19 disease 2019. [6] [7]

Ebola response

Emory University Hospital received the first patient with Ebola virus disease, a missionary and physician named Kent Brantly, on August 2, 2014, followed by three patients with the disease, including the physician Ian Crozier. [8] [9] During that time, she worked on developing a protocol for the first known successful delivery of renal replacement therapy to treat kidney failure in Ebola patients. [10] [11] Kraft is a co-PI for the National Ebola Training and Education Center, a federally funded collaborative between Emory University, Nebraska Medicine, and New York Health and Hospital-Bellevue that is working to address gaps in outbreak preparedness. [12] As a result, Emory's Serious Communicable Diseases Unit remains prepared to treat Ebola patients. [13]

COVID-19 response

In response to the COVID-19 pandemic, Kraft was appointed to the 18-member task force of health, airport, school and emergency preparedness officials to address and mitigate the spread of COVID-19 in Georgia, advising Governor Brian Kemp. [14] [15] As Associate Chief Medical Officer, she is also coordinating the response to the pandemic across Emory University's healthcare system, working to ensure that healthcare workers on the frontlines do not contract the disease and avoid burnout. [16] They have already launched three in-house testing platforms that can provide COVID-19 testing results in 24 hours, as opposed to commercial labs that were taking 7–10 days. [17]

Kraft was part of a research team that found that reusable respirators, which are typically used by construction or factory workers, could be a suitable alternative to the disposable N95 masks currently used by physicians treating COVID-19 patients. [18] [19] Healthcare workers can be rapidly fit tested and trained on how to use the reusable masks, and use of such masks can address the current shortage of N95 masks. There is currently no stockpile of reusable respirators, however, construction workers have begun donating them to local hospitals. [20] Kraft is also working with researchers at Georgia Tech to supply the medical community with 3D printers and laser-cutting machines to make protective gear. [21]

Awards and honors

Selected publications

Related Research Articles

<span class="mw-page-title-main">Centers for Disease Control and Prevention</span> United States government public health agency

The Centers for Disease Control and Prevention (CDC) is the national public health agency of the United States. It is a United States federal agency under the Department of Health and Human Services, and is headquartered in Atlanta, Georgia.

<span class="mw-page-title-main">Surgical mask</span> Mouth and nose cover against bacterial aerosols

A surgical mask, also known by other names such as a medical face mask or procedure mask, is a personal protective equipment used by healthcare professionals that serves as a mechanical barrier that interferes with direct airflow in and out of respiratory orifices. This helps reduce airborne transmission of pathogens and other aerosolized contaminants between the wearer and nearby people via respiratory droplets ejected when sneezing, coughing, forceful expiration or unintentionally spitting when talking, etc. Surgical masks may be labeled as surgical, isolation, dental or medical procedure masks.

<span class="mw-page-title-main">University of Nebraska Medical Center</span> Medical center in Omaha, Nebraska, United States

The University of Nebraska Medical Center (UNMC) is a public academic health science center in Omaha, Nebraska. Founded in 1869 and chartered as a private medical college in 1881, UNMC became part of the University of Nebraska System in 1902. Rapidly expanding in the early 20th century, the university founded a hospital, dental college, pharmacy college, college of nursing, and college of medicine. It later added colleges of public health and allied health professions. One of Omaha's top employers, UNMC has an annual budget of $841.6 million for 2020 to 2021, and an economic impact of $4.8 billion.

<span class="mw-page-title-main">Isolation (health care)</span> Measure taken to prevent contagious diseases from being spread

In health care facilities, isolation represents one of several measures that can be taken to implement in infection control: the prevention of communicable diseases from being transmitted from a patient to other patients, health care workers, and visitors, or from outsiders to a particular patient. Various forms of isolation exist, in some of which contact procedures are modified, and others in which the patient is kept away from all other people. In a system devised, and periodically revised, by the U.S. Centers for Disease Control and Prevention (CDC), various levels of patient isolation comprise application of one or more formally described "precaution".

<span class="mw-page-title-main">Emory University Hospital</span> Hospital in Georgia, USA

Nebraska Medicine, is a private not-for-profit American healthcare company based in Omaha, Nebraska. The company was created as Nebraska Health System (NHS) in 1997, when Bishop Clarkson Hospital merged with the adjacent University Hospital in midtown Omaha. Renamed The Nebraska Medical Center in 2003, in 2014 the company merged with UNMC Physicians and Bellevue Medical Center to become Nebraska Medicine. The company has full ownership of two hospitals and 39 specialty and primary care clinics in and around Omaha, with partial ownership in two rural hospitals and a specialty hospital. Nebraska Medicine's main campus, Nebraska Medicine – Nebraska Medical Center, has 718 beds, while its Bellevue Medical Center campus has 91 beds.

<span class="mw-page-title-main">Favipiravir</span> Experimental antiviral drug with potential activity against RNA viruses

Favipiravir, sold under the brand name Avigan among others, is an antiviral medication used to treat influenza in Japan. It is also being studied to treat a number of other viral infections, including SARS-CoV-2. Like the experimental antiviral drugs T-1105 and T-1106, it is a pyrazinecarboxamide derivative.

<span class="mw-page-title-main">N95 respirator</span> Particulate respirator meeting the N95 standard

An N95 filtering facepiece respirator, commonly abbreviated N95 respirator, is a particulate-filtering facepiece respirator that meets the U.S. National Institute for Occupational Safety and Health (NIOSH) N95 classification of air filtration, meaning that it filters at least 95% of airborne particles that have a mass median aerodynamic diameter of 0.3 micrometers. This standard does not require that the respirator be resistant to oil; another standard, P95, adds that requirement. The N95 type is the most common particulate-filtering facepiece respirator. It is an example of a mechanical filter respirator, which provides protection against particulates but not against gases or vapors. An authentic N95 respirator is marked with the text "NIOSH" or the NIOSH logo, the filter class ("N95"), a "TC" approval number of the form XXX-XXXX, the approval number must be listed on the NIOSH Certified Equipment List (CEL) or the NIOSH Trusted-Source page, and it must have headbands instead of ear loops.

<span class="mw-page-title-main">Syra Madad</span> American pathogen preparedness expert

Syra Madad is an American pathogen preparedness expert and infectious disease epidemiologist. Madad is the Senior Director of the System-wide Special Pathogens Program at NYC Health + Hospitals where she is part of the executive leadership team which oversees New York City's response to the Coronavirus disease 2019 pandemic in the city's 11 public hospitals. She was featured in the Netflix documentary series Pandemic: How to Prevent an Outbreak and the Discovery Channel documentary The Vaccine: Conquering COVID.

<span class="mw-page-title-main">Caitlin Rivers</span> American emerging infectious disease epidemiologist

Caitlin M. Rivers is an American epidemiologist who as Senior Scholar at the Johns Hopkins Center for Health Security and assistant professor at the Johns Hopkins Bloomberg School of Public Health, specializing on improving epidemic preparedness. Rivers is currently working on the American response to the COVID-19 pandemic with a focus on the incorporation of infectious disease modeling and forecasting into public health decision making.

<span class="mw-page-title-main">Convalescent plasma</span> Blood plasma from disease survivor

Convalescent plasma is the blood plasma collected from a survivor of an infectious disease. This plasma contains antibodies specific to a pathogen and can be used therapeutically by providing passive immunity when transfusing it to a newly infected patient with the same condition. Convalescent plasma can be transfused as it has been collected or become the source material for the hyperimmune serum which consists largely of IgG but also includes IgA and IgM. or as source material for anti-pathogen monoclonal antibodies, Collection is typically achieved by apheresis, but in low-to-middle income countries, the treatment can be administered as convalescent whole blood.

<span class="mw-page-title-main">Cloth face mask</span> Mask made of common textiles worn over the mouth and nose

A cloth face mask is a mask made of common textiles, usually cotton, worn over the mouth and nose. When more effective masks are not available, and when physical distancing is impossible, cloth face masks are recommended by public health agencies for disease "source control" in epidemic situations to protect others from virus laden droplets in infected mask wearers' breath, coughs, and sneezes. Because they are less effective than N95 masks, surgical masks, or physical distancing in protecting the wearer against viruses, they are not considered to be personal protective equipment by public health agencies. They are used by the general public in household and community settings as protection against both infectious diseases and particulate air pollution.

Allison Joan McGeer is a Canadian infectious disease specialist in the Sinai Health System, and a professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto. She also appointed at the Dalla Lana School of Public Health and a Senior Clinician Scientist at the Lunenfeld-Tanenbaum Research Institute, and is a partner of the National Collaborating Centre for Infectious Diseases. McGeer has led investigations into the severe acute respiratory syndrome outbreak in Toronto and worked alongside Donald Low. During the COVID-19 pandemic, McGeer has studied how SARS-CoV-2 survives in the air and has served on several provincial committees advising aspects of the Government of Ontario's pandemic response.

<span class="mw-page-title-main">Mechanical filter (respirator)</span> Air-filtering face masks or mask attachments

Mechanical filters are a class of filter for air-purifying respirators that mechanically stops particulates from reaching the wearer's nose and mouth. They come in multiple physical forms.

<span class="mw-page-title-main">Face masks during the COVID-19 pandemic</span> Health control procedure against COVID-19

During the COVID-19 pandemic, face masks or coverings, including N95, FFP2, surgical, and cloth masks, have been employed as public and personal health control measures against the spread of SARS-CoV-2, the virus that causes COVID-19.

<span class="mw-page-title-main">Source control (respiratory disease)</span> Strategy for reducing disease transmission

Source control is a strategy for reducing disease transmission by blocking respiratory secretions produced through speaking, coughing, sneezing or singing. Surgical masks are commonly used for this purpose, with cloth face masks recommended for use by the public only in epidemic situations when there are shortages of surgical masks. In addition, respiratory etiquette such as covering the mouth and nose with a tissue when coughing can be considered source control. In diseases transmitted by droplets or aerosols, understanding air flow, particle and aerosol transport may lead to rational infrastructural source control measures that minimize exposure of susceptible persons.

David Alain Wohl is an American infectious disease physician. During the COVID-19 pandemic, he was among those leading UNC's response to the SARS-CoV-2 pandemic. Wohl was appointed the Medical Director of the COVID Vaccination Clinic at UNC Hospitals Hillsborough Campus and led COVID-19 treatment clinical trials at UNC School of Medicine.

John J. Lowe is an American infectious disease scientist, assistant vice chancellor for health security at University of Nebraska Medical Center, and associate professor in the Department of Environmental, Agricultural and Occupational Health at University of Nebraska Medical Center College of Public Health. In 2014, he led Nebraska Medicine hospital’s effort to treat and care for Ebola virus disease patients and led the University of Nebraska Medical Center’s coronavirus disease 2019 response efforts.

Wilkins Infectious Diseases Hospital is Zimbabwe's main hospital for treating and testing infectious diseases caused by bacteria, viruses, fungi or parasites. The hospital is the main isolation and treatment centre as well as the main vaccination centre for coronavirus in Zimbabwe.

Nicole M. Bouvier is an American physician who is Professor of Medicine at Icahn School of Medicine at Mount Sinai. Her research considers the environmental and viral factors that impact respiratory transmission of influenza viruses.

References

  1. ↑ "Taylor University Commencement 1998". Taylor University (taylor.edu). May 28, 1998.
  2. 1 2 3 "Dr. Colleen S Kraft, MD - Atlanta, GA - Infectious Diseases - Request Appointment". providers.emoryhealthcare.org. Retrieved April 9, 2020.
  3. ↑ Zhang, Sarah (June 24, 2019). "Should Human Feces Be Regulated Like a Drug?". The Atlantic. Retrieved April 9, 2020.
  4. ↑ Khanna, Sahil; Pardi, Darrell S.; Kelly, Colleen R.; Kraft, Colleen S.; Dhere, Tanvi; Henn, Matthew R.; Lombardo, Mary-Jane; Vulic, Marin; Ohsumi, Toshiro; Winkler, Jonathan; Pindar, Christina (July 15, 2016). "A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents Recurrent Clostridium difficile Infection". The Journal of Infectious Diseases. 214 (2): 173–181. doi: 10.1093/infdis/jiv766 . ISSN   0022-1899. PMID   26908752.
  5. ↑ Aleccia, JoNel; Writer, Senior (May 11, 2013). "Not 'glamorous': Doc is universal donor for fecal transplants". NBC News. Retrieved April 9, 2020.
  6. ↑ "'Please don't cry, Dr. Kraft': How one doctor is handling the coronavirus pandemic". Los Angeles Times. April 8, 2020. Archived from the original on April 9, 2020. Retrieved March 22, 2021.
  7. ↑ "Profile | Emory School of Medicine".
  8. ↑ Beaubien, Jason. "Ebola Survivor: The Best Word For The Virus Is 'Aggression'". NPR.org. Retrieved April 9, 2020.
  9. ↑ Lyon, G. Marshall; Mehta, Aneesh K.; Varkey, Jay B.; Brantly, Kent; Plyler, Lance; McElroy, Anita K.; Kraft, Colleen S.; Towner, Jonathan S.; Spiropoulou, Christina; Ströher, Ute; Uyeki, Timothy M. (December 18, 2014). "Clinical Care of Two Patients with Ebola Virus Disease in the United States". New England Journal of Medicine. 371 (25): 2402–2409. doi: 10.1056/NEJMoa1409838 . ISSN   0028-4793. PMID   25390460.
  10. ↑ "Faith, Medicine or ZMapp? What Cured The Ebola Patients?". NBC News. September 5, 2014. Retrieved April 10, 2020.
  11. ↑ Connor, Michael J.; Kraft, Colleen; Mehta, Aneesh K.; Varkey, Jay B.; Lyon, G. Marshall; Crozier, Ian; Ströher, Ute; Ribner, Bruce S.; Franch, Harold A. (January 1, 2015). "Successful Delivery of RRT in Ebola Virus Disease". Journal of the American Society of Nephrology. 26 (1): 31–37. doi: 10.1681/ASN.2014111057 . ISSN   1046-6673. PMC   4279752 . PMID   25398785.
  12. ↑ Vanairsdale, Sharon; Mehta, Aneesh K; Kraft, Colleen (October 4, 2017). "Ebola and Beyond-Developing an Infectious Diseases Treatment Infrastructure in the United States". Open Forum Infectious Diseases. 4 (Suppl 1): S244. doi:10.1093/ofid/ofx163.521. ISSN   2328-8957. PMC   5631736 .
  13. ↑ Prescott, La'Raven Taylor , Virginia (September 10, 2019). "Emory Remains Prepared To Treat Ebola Patients, 5 Years Later". www.gpbnews.org. Retrieved April 10, 2020.{{cite web}}: CS1 maint: multiple names: authors list (link)
  14. ↑ "Georgia Governor Creates Coronavirus Task Force". U.S. News & World Report. February 28, 2020. Retrieved April 9, 2020.
  15. ↑ Maya T. Prabhu, The Atlanta Journal-Constitution. "Gov. Brian Kemp names Georgia coronavirus task force". The Atlanta Journal-Constitution. Retrieved April 9, 2020.
  16. ↑ Netburn, Deborah (April 8, 2020). "'Please don't cry, Dr. Kraft': How one doctor is handling the coronavirus pandemic". Los Angeles Times. Retrieved April 9, 2020.
  17. ↑ Richardson, Savannah (April 3, 2020). "Rapid testing for coronavirus starts in Albany, Atlanta". The Brunswick News. Retrieved April 9, 2020.
  18. ↑ Mundell, E.J. (March 27, 2020). "Respirator Masks - In Short Supply". WebMD. Retrieved April 9, 2020.
  19. ↑ "Reusable respirators a potential alternative for protecting health care workers from COVID-19". news.emory.edu. March 26, 2020. Retrieved April 9, 2020.
  20. ↑ "Reusable respirators protect doctors and nurses against coronavirus, they aren't in the national stockpile". azcentral. Retrieved April 9, 2020.
  21. ↑ Helena Oliviero, The Atlanta Journal-Constitution. "Emory hospital prepares for 'super surge' of COVID-19 patients". The Atlanta Journal-Constitution. Retrieved April 9, 2020.
  22. ↑ "Colleen Kraft, MD elected to serve as 2022 president of the American Society for Microbiology". Emory Daily Pulse Blog, Emory University School of Medicine. December 9, 2020.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.